Insider · CIK 0001650131

Radovich Peter

Reports to the SEC for 4 companies · CARMEL, IN

sec.gov

Transactions

Companies

Filings

CIK

0001650131

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-20	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director	AAward	+18.2K sh	—	—	18,200
2026-06-05	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+17K sh	$19.19	+$326K	57,260
2026-06-05	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−17K sh	—	—	48,012
2026-03-16	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−16.5K sh	$91.98	−$1.52M	40,272
2026-03-15	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+7,220 sh	—	—	33,787
2026-03-15	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+23K sh	—	—	56,787
2026-03-15	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−7,220 sh	—	—	0
2026-03-15	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−23K sh	—	—	11,500
2026-03-06	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+5,912 sh	$15.87	+$93.8K	26,567
2026-03-06	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−5,912 sh	—	—	54,088
2026-02-02	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−2,631 sh	$103.30	−$272K	20,655
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	PRESIDENT AND COO	AAward	+25.1K sh	—	—	25,120
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	PRESIDENT AND COO	AAward	+16.3K sh	—	—	16,280
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsA Award	PRESIDENT AND COO	AAward	+34.5K sh	—	—	34,500
2026-01-26	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−3,143 sh	$96.19	−$302K	23,286
2026-01-23	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+5,750 sh	—	—	26,429
2026-01-23	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−5,750 sh	—	—	5,750
2026-01-22	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−2,382 sh	$93.33	−$222K	20,679
2026-01-21	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+4,167 sh	—	—	23,061
2026-01-21	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−4,167 sh	—	—	8,333
2025-03-17	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−7,879 sh	$44.21	−$348K	18,672
2025-03-15	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+14.4K sh	—	—	26,551
2025-03-15	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−14.4K sh	—	—	7,220
2025-03-04	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−13.7K sh	$45.57	−$623K	13,280
2025-03-04	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−1,169 sh	$45.74	−$53.5K	12,111
2025-02-03	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−2,627 sh	$48.22	−$127K	26,961
2025-01-24	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−3,177 sh	$47.92	−$152K	29,588
2025-01-23	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	+5,750 sh	—	—	32,765
2025-01-23	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	PRESIDENT AND COO	MExercise/Conversion	−5,750 sh	—	—	11,500
2025-01-21	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	PRESIDENT AND COO	AAward	+50K sh	—	—	50,000
2025-01-21	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	PRESIDENT AND COO	AAward	+12.5K sh	—	—	12,500
2025-01-21	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsA Award	PRESIDENT AND COO	AAward	+21.7K sh	—	—	21,660
2025-01-07	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−1,998 sh	$42.82	−$85.5K	27,015
2024-03-25	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−4,303 sh	$25.80	−$111K	29,013
2024-02-02	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−1,790 sh	$26.19	−$46.9K	34,695
2024-01-26	Rain Oncology Inc.U Disposition from Tender	Director	UDisposition from Tender	−8,796 sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42.6K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2024-01-23	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	PRESIDENT AND COO	AAward	+70K sh	—	—	70,000
2024-01-23	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	PRESIDENT AND COO	AAward	+17.3K sh	—	—	17,250
2024-01-08	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−1,408 sh	$28.03	−$39.5K	36,485
2023-11-10	MIRMMirum Pharmaceuticals, Inc.A Award	PRESIDENT AND COO	AAward	+218 sh	$22.29	+$4,858.566	37,893
2023-08-09	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-07-03	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−1,425 sh	$25.65	−$36.5K	37,675
2023-05-10	MIRMMirum Pharmaceuticals, Inc.A Award	PRESIDENT AND COO	AAward	+968 sh	$16.92	+$16.4K	39,100
2023-01-31	MIRMMirum Pharmaceuticals, Inc.A Award	PRESIDENT AND COO	AAward	+14.4K sh	—	—	38,132
2023-01-31	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	PRESIDENT AND COO	AAward	+57.8K sh	—	—	57,750
2023-01-09	MIRMMirum Pharmaceuticals, Inc.S Sale	PRESIDENT AND COO	SSale	−1,379 sh	$20.62	−$28.4K	33,316

Recent filings

Accepted (ET)
Oct 224
Radovich Peter0001193125-26-428390
SEC(opens sec.gov)
Jun 84
Radovich Peter0001650131-26-000011
SEC(opens sec.gov)
Mar 174
Radovich Peter0001650131-26-000010
SEC(opens sec.gov)
Mar 114
Radovich Peter0001650131-26-000008
SEC(opens sec.gov)
Feb 34
Radovich Peter0001650131-26-000007
SEC(opens sec.gov)
Jan 304
Radovich Peter0001650131-26-000005
SEC(opens sec.gov)
Jan 274
Radovich Peter0001650131-26-000003
SEC(opens sec.gov)
Jan 234
Radovich Peter0001650131-26-000002
SEC(opens sec.gov)

Companies

Address

11711 N. MERIDIAN STREET SUITE 300

CARMEL, IN, 46032